Filing identity and reporting period
Important entity mismatch: The supplied filing is Foley Trasimene Acquisition Corp.’s unaudited Form 10-Q for the quarter ended September 30, 2020—not an Alight, Inc. filing. Foley Trasimene was a blank-check company formed to pursue a business combination, with an intended focus on financial technology or business process outsourcing. It had not selected a target or begun substantive discussions with one as of the filing.
Financial results and liquidity
- Revenue and operations: No operating revenue; the company had not commenced operations. Third-quarter net income was $155,641, principally reflecting $394,825 of trust-account interest, offset by expenses and income taxes. Net income from inception on March 26 through September 30 was $154,057. No operating margins are meaningful for this pre-combination company.
- Expense discrepancy: The statements report third-quarter formation and general and administrative expenses of $166,771, while MD&A states operating costs of $161,771. The filing text does not reconcile these figures.
- Assets and liquidity: Total assets were $1.036 billion, including $1.036 billion in cash and marketable securities held in the trust account. Cash outside the trust was $579,370; management reported working capital of approximately $635,000. Trust funds were principally restricted for a business combination or shareholder redemptions.
- Cash flow: From inception through September 30, operating activities used $440,676; investing activities used $1.035 billion, placed in the trust; financing activities provided $1.037 billion. Ending cash outside the trust was $579,370.
- Debt and obligations: No long-term debt or working-capital loans were outstanding. The balance sheet included a $36.225 million deferred underwriting fee, payable only if a business combination closes. Stockholders’ equity was $5.0 million; 99.5 million Class A shares, valued at $994.9 million, were classified as subject to possible redemption.
Changes, outlook, and risks
This is the company’s first year of operations, so the filing provides no prior-year comparable period. The $1.035 billion IPO closed on May 29, 2020, alongside a $22.7 million private placement warrant sale. Two forward purchase agreements provide for a combined $300 million investment at a business-combination closing, subject to their terms.
Management expected available working capital and potential sponsor borrowing to cover needs through a business combination or one year from the filing. The company had until May 29, 2022 to complete a business combination; otherwise, it generally must redeem public shares and liquidate. Management said COVID-19 could adversely affect the target search and transaction timing, but the specific impact was not determinable. The filing gives no operating forecast or target-specific outlook. It reports no material changes to previously disclosed risk factors, no legal proceedings, and effective disclosure controls.
Potential investor concerns include redemption-driven dilution, founder-share conversion terms, possible additional equity or debt financing, and the risk that warrants expire worthless if no transaction closes. On November 5, 2020, the board amended the bylaws to increase the maximum number of directors from five to 14.
Facts investors should verify
- Confirm the intended issuer: this filing is for Foley Trasimene Acquisition Corp., not Alight, Inc.
- Reconcile the $166,771 expense in the financial statements with the $161,771 amount in MD&A.
- Review trust-account restrictions, redemption mechanics, and the May 29, 2022 business-combination deadline.
- Assess dilution and financing terms, including the founder-share conversion provisions and the $300 million forward purchase agreements.
- Monitor the target search and the potential effect of COVID-19 on transaction execution.